FDC Limited Share Price NSE India S.E.

Equities

FDC

INE258B01022

Pharmaceuticals

Market Closed - NSE India S.E. 12:43:47 26/04/2024 BST 5-day change 1st Jan Change
456.7 INR -0.05% Intraday chart for FDC Limited +1.78% +15.20%

Financials

Sales 2022 15.28B 183M 14.67B Sales 2023 17.84B 214M 17.13B Capitalization 42.56B 511M 40.87B
Net income 2022 2.16B 25.96M 2.08B Net income 2023 1.94B 23.27M 1.86B EV / Sales 2022 2.51 x
Net cash position 2022 5.06B 60.72M 4.86B Net cash position 2023 4.53B 54.32M 4.35B EV / Sales 2023 2.13 x
P/E ratio 2022
20 x
P/E ratio 2023
22 x
Employees 6,372
Yield 2022 *
-
Yield 2023
-
Free-Float 30.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.05%
1 week+1.78%
Current month+7.48%
1 month+7.74%
3 months+9.45%
6 months+25.45%
Current year+15.20%
More quotes
1 week
442.05
Extreme 442.05
460.00
1 month
427.25
Extreme 427.25
460.00
Current year
392.00
Extreme 392
487.70
1 year
282.05
Extreme 282.05
487.70
3 years
225.00
Extreme 225
487.70
5 years
151.20
Extreme 151.2
487.70
10 years
117.00
Extreme 117
487.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 88 21/04/67
Chief Executive Officer 61 30/09/93
Director of Finance/CFO - 05/04/23
Members of the board TitleAgeSince
Chief Executive Officer 61 30/09/93
Director/Board Member - 31/12/99
Chief Executive Officer 88 21/04/67
More insiders
Date Price Change Volume
26/04/24 456.7 -0.05% 46,681
25/04/24 457 +0.95% 60,837
24/04/24 452.6 +1.98% 80,501
23/04/24 443.8 -1.49% 81,728
22/04/24 450.6 +0.41% 44,580

Delayed Quote NSE India S.E., April 26, 2024 at 12:43 pm

More quotes
FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations, and active pharmaceuticals at its manufacturing plants. It also manufactures oral rehydration salts (ORS) and specialized formulations. It has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. It has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
More about the company

Quarterly revenue - Rate of surprise